share_log

Lam Research | 8-K: Lam Research Corporation Reports Financial Results for the Quarter Ended September 29, 2024

SEC ·  Oct 23, 2024 13:12

Summary by Moomoo AI

Lam Research Corporation reported robust financial results for Q1 FY2025 ended September 29, 2024, surpassing expectations. Revenue reached $4.17 billion, an 8% increase from the previous quarter. U.S. GAAP diluted EPS rose 10% to $0.86, while non-GAAP diluted EPS grew 6% to $0.86.The company demonstrated strong operational execution, with U.S. GAAP gross margin improving to 48.0% and operating income as a percentage of revenue increasing to 30.3%. Lam's strategic investments in key technology inflections have positioned it well to outperform WFE growth in 2025 and beyond.For Q2 FY2025, Lam projects revenue of $4.30 billion ±$300 million and diluted EPS of $0.87 ±$0.10 on both a U.S. GAAP and non-GAAP basis. The company's cash position strengthened to $6.1 billion, reflecting robust cash generation from operations.
Lam Research Corporation reported robust financial results for Q1 FY2025 ended September 29, 2024, surpassing expectations. Revenue reached $4.17 billion, an 8% increase from the previous quarter. U.S. GAAP diluted EPS rose 10% to $0.86, while non-GAAP diluted EPS grew 6% to $0.86.The company demonstrated strong operational execution, with U.S. GAAP gross margin improving to 48.0% and operating income as a percentage of revenue increasing to 30.3%. Lam's strategic investments in key technology inflections have positioned it well to outperform WFE growth in 2025 and beyond.For Q2 FY2025, Lam projects revenue of $4.30 billion ±$300 million and diluted EPS of $0.87 ±$0.10 on both a U.S. GAAP and non-GAAP basis. The company's cash position strengthened to $6.1 billion, reflecting robust cash generation from operations.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Doc 2

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Related Stocks Related Stocks
    Symbol Mini Chart Price
    Amtech Systems
    ASYS
    -- 5.840
    AXT Inc
    AXTI
    -- 2.230
    FormFactor
    FORM
    -- 37.800
    ACM Research
    ACMR
    -- 23.780
    Aehr Test Systems
    AEHR
    -- 10.720
    Log In for the Full List
    Reassessing Chinese Assets
    Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
    Discussing
    FOMC leaves rates unchanged, how will you adjust your portfolio?
    FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More
    FOMC Press Conference, January 29, 2025